The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharma Sustained Release Excipient Market Research Report 2025
Synopsis
The global Pharma Sustained Release Excipient market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharma Sustained Release Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Sustained Release Excipient.
Report Scope
The Pharma Sustained Release Excipient market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Sustained Release Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Sustained Release Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Chitosan
Segment by Application
Pharmaceutical
Health Care
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma Sustained Release Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharma Sustained Release Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pharma Sustained Release Excipient market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharma Sustained Release Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Sustained Release Excipient.
Report Scope
The Pharma Sustained Release Excipient market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Sustained Release Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Sustained Release Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Chitosan
Segment by Application
Pharmaceutical
Health Care
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma Sustained Release Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharma Sustained Release Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pharma Sustained Release Excipient Market Overview
1.1 Product Overview and Scope of Pharma Sustained Release Excipient
1.2 Pharma Sustained Release Excipient Segment by Type
1.2.1 Global Pharma Sustained Release Excipient Market Value Comparison by Type (2024-2030)
1.2.2 Gelatin
1.2.3 Polymers
1.2.4 Minerals
1.2.5 Sugars
1.2.6 Chitosan
1.3 Pharma Sustained Release Excipient Segment by Application
1.3.1 Global Pharma Sustained Release Excipient Market Value by Application: (2024-2030)
1.3.2 Pharmaceutical
1.3.3 Health Care
1.3.4 Others
1.4 Global Pharma Sustained Release Excipient Market Size Estimates and Forecasts
1.4.1 Global Pharma Sustained Release Excipient Revenue 2019-2030
1.4.2 Global Pharma Sustained Release Excipient Sales 2019-2030
1.4.3 Global Pharma Sustained Release Excipient Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharma Sustained Release Excipient Market Competition by Manufacturers
2.1 Global Pharma Sustained Release Excipient Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pharma Sustained Release Excipient Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pharma Sustained Release Excipient Average Price by Manufacturers (2019-2024)
2.4 Global Pharma Sustained Release Excipient Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharma Sustained Release Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharma Sustained Release Excipient, Product Type & Application
2.7 Pharma Sustained Release Excipient Market Competitive Situation and Trends
2.7.1 Pharma Sustained Release Excipient Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharma Sustained Release Excipient Players Market Share by Revenue
2.7.3 Global Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharma Sustained Release Excipient Retrospective Market Scenario by Region
3.1 Global Pharma Sustained Release Excipient Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharma Sustained Release Excipient Global Pharma Sustained Release Excipient Sales by Region: 2019-2030
3.2.1 Global Pharma Sustained Release Excipient Sales by Region: 2019-2024
3.2.2 Global Pharma Sustained Release Excipient Sales by Region: 2025-2030
3.3 Global Pharma Sustained Release Excipient Global Pharma Sustained Release Excipient Revenue by Region: 2019-2030
3.3.1 Global Pharma Sustained Release Excipient Revenue by Region: 2019-2024
3.3.2 Global Pharma Sustained Release Excipient Revenue by Region: 2025-2030
3.4 North America Pharma Sustained Release Excipient Market Facts & Figures by Country
3.4.1 North America Pharma Sustained Release Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharma Sustained Release Excipient Sales by Country (2019-2030)
3.4.3 North America Pharma Sustained Release Excipient Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharma Sustained Release Excipient Market Facts & Figures by Country
3.5.1 Europe Pharma Sustained Release Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharma Sustained Release Excipient Sales by Country (2019-2030)
3.5.3 Europe Pharma Sustained Release Excipient Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharma Sustained Release Excipient Market Facts & Figures by Country
3.6.1 Asia Pacific Pharma Sustained Release Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharma Sustained Release Excipient Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharma Sustained Release Excipient Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharma Sustained Release Excipient Market Facts & Figures by Country
3.7.1 Latin America Pharma Sustained Release Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharma Sustained Release Excipient Sales by Country (2019-2030)
3.7.3 Latin America Pharma Sustained Release Excipient Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharma Sustained Release Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharma Sustained Release Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharma Sustained Release Excipient Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharma Sustained Release Excipient Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharma Sustained Release Excipient Sales by Type (2019-2030)
4.1.1 Global Pharma Sustained Release Excipient Sales by Type (2019-2024)
4.1.2 Global Pharma Sustained Release Excipient Sales by Type (2025-2030)
4.1.3 Global Pharma Sustained Release Excipient Sales Market Share by Type (2019-2030)
4.2 Global Pharma Sustained Release Excipient Revenue by Type (2019-2030)
4.2.1 Global Pharma Sustained Release Excipient Revenue by Type (2019-2024)
4.2.2 Global Pharma Sustained Release Excipient Revenue by Type (2025-2030)
4.2.3 Global Pharma Sustained Release Excipient Revenue Market Share by Type (2019-2030)
4.3 Global Pharma Sustained Release Excipient Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharma Sustained Release Excipient Sales by Application (2019-2030)
5.1.1 Global Pharma Sustained Release Excipient Sales by Application (2019-2024)
5.1.2 Global Pharma Sustained Release Excipient Sales by Application (2025-2030)
5.1.3 Global Pharma Sustained Release Excipient Sales Market Share by Application (2019-2030)
5.2 Global Pharma Sustained Release Excipient Revenue by Application (2019-2030)
5.2.1 Global Pharma Sustained Release Excipient Revenue by Application (2019-2024)
5.2.2 Global Pharma Sustained Release Excipient Revenue by Application (2025-2030)
5.2.3 Global Pharma Sustained Release Excipient Revenue Market Share by Application (2019-2030)
5.3 Global Pharma Sustained Release Excipient Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva Pharmaceutical Industries
6.1.1 Teva Pharmaceutical Industries Corporation Information
6.1.2 Teva Pharmaceutical Industries Description and Business Overview
6.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Portfolio
6.1.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.2 Mylan N.V.
6.2.1 Mylan N.V. Corporation Information
6.2.2 Mylan N.V. Description and Business Overview
6.2.3 Mylan N.V. Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan N.V. Pharma Sustained Release Excipient Product Portfolio
6.2.5 Mylan N.V. Recent Developments/Updates
6.3 Valeant Pharmaceuticals International
6.3.1 Valeant Pharmaceuticals International Corporation Information
6.3.2 Valeant Pharmaceuticals International Description and Business Overview
6.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Portfolio
6.3.5 Valeant Pharmaceuticals International Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Pharma Sustained Release Excipient Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis AG Pharma Sustained Release Excipient Product Portfolio
6.6.5 Novartis AG Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Pharma Sustained Release Excipient Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GlaxoSmithKline Pharma Sustained Release Excipient Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Corporation Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Allergan Pharma Sustained Release Excipient Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Janssen Pharmaceuticals
6.10.1 Janssen Pharmaceuticals Corporation Information
6.10.2 Janssen Pharmaceuticals Description and Business Overview
6.10.3 Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Portfolio
6.10.5 Janssen Pharmaceuticals Recent Developments/Updates
6.11 Mayne Pharma Group
6.11.1 Mayne Pharma Group Corporation Information
6.11.2 Mayne Pharma Group Pharma Sustained Release Excipient Description and Business Overview
6.11.3 Mayne Pharma Group Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mayne Pharma Group Pharma Sustained Release Excipient Product Portfolio
6.11.5 Mayne Pharma Group Recent Developments/Updates
6.12 BASF
6.12.1 BASF Corporation Information
6.12.2 BASF Pharma Sustained Release Excipient Description and Business Overview
6.12.3 BASF Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BASF Pharma Sustained Release Excipient Product Portfolio
6.12.5 BASF Recent Developments/Updates
6.13 International Flavors & Fragrances
6.13.1 International Flavors & Fragrances Corporation Information
6.13.2 International Flavors & Fragrances Pharma Sustained Release Excipient Description and Business Overview
6.13.3 International Flavors & Fragrances Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.13.4 International Flavors & Fragrances Pharma Sustained Release Excipient Product Portfolio
6.13.5 International Flavors & Fragrances Recent Developments/Updates
6.14 Ashland Global
6.14.1 Ashland Global Corporation Information
6.14.2 Ashland Global Pharma Sustained Release Excipient Description and Business Overview
6.14.3 Ashland Global Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ashland Global Pharma Sustained Release Excipient Product Portfolio
6.14.5 Ashland Global Recent Developments/Updates
6.15 Evonik Industries
6.15.1 Evonik Industries Corporation Information
6.15.2 Evonik Industries Pharma Sustained Release Excipient Description and Business Overview
6.15.3 Evonik Industries Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Evonik Industries Pharma Sustained Release Excipient Product Portfolio
6.15.5 Evonik Industries Recent Developments/Updates
6.16 Croda International
6.16.1 Croda International Corporation Information
6.16.2 Croda International Pharma Sustained Release Excipient Description and Business Overview
6.16.3 Croda International Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Croda International Pharma Sustained Release Excipient Product Portfolio
6.16.5 Croda International Recent Developments/Updates
6.17 Gattefosse
6.17.1 Gattefosse Corporation Information
6.17.2 Gattefosse Pharma Sustained Release Excipient Description and Business Overview
6.17.3 Gattefosse Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Gattefosse Pharma Sustained Release Excipient Product Portfolio
6.17.5 Gattefosse Recent Developments/Updates
6.18 Merck KGaA
6.18.1 Merck KGaA Corporation Information
6.18.2 Merck KGaA Pharma Sustained Release Excipient Description and Business Overview
6.18.3 Merck KGaA Pharma Sustained Release Excipient Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Merck KGaA Pharma Sustained Release Excipient Product Portfolio
6.18.5 Merck KGaA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharma Sustained Release Excipient Industry Chain Analysis
7.2 Pharma Sustained Release Excipient Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharma Sustained Release Excipient Production Mode & Process
7.4 Pharma Sustained Release Excipient Sales and Marketing
7.4.1 Pharma Sustained Release Excipient Sales Channels
7.4.2 Pharma Sustained Release Excipient Distributors
7.5 Pharma Sustained Release Excipient Customers
8 Pharma Sustained Release Excipient Market Dynamics
8.1 Pharma Sustained Release Excipient Industry Trends
8.2 Pharma Sustained Release Excipient Market Drivers
8.3 Pharma Sustained Release Excipient Market Challenges
8.4 Pharma Sustained Release Excipient Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pharma Sustained Release Excipient Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pharma Sustained Release Excipient Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pharma Sustained Release Excipient Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pharma Sustained Release Excipient Sales (Kiloton) of Key Manufacturers (2019-2024)
Table 5. Global Pharma Sustained Release Excipient Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pharma Sustained Release Excipient Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pharma Sustained Release Excipient, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharma Sustained Release Excipient, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharma Sustained Release Excipient, Product Type & Application
Table 12. Global Key Manufacturers of Pharma Sustained Release Excipient, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharma Sustained Release Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sustained Release Excipient as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharma Sustained Release Excipient Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kiloton)
Table 18. Global Pharma Sustained Release Excipient Sales Market Share by Region (2019-2024)
Table 19. Global Pharma Sustained Release Excipient Sales by Region (2025-2030) & (Kiloton)
Table 20. Global Pharma Sustained Release Excipient Sales Market Share by Region (2025-2030)
Table 21. Global Pharma Sustained Release Excipient Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pharma Sustained Release Excipient Revenue Market Share by Region (2019-2024)
Table 23. Global Pharma Sustained Release Excipient Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pharma Sustained Release Excipient Revenue Market Share by Region (2025-2030)
Table 25. North America Pharma Sustained Release Excipient Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kiloton)
Table 27. North America Pharma Sustained Release Excipient Sales by Country (2025-2030) & (Kiloton)
Table 28. North America Pharma Sustained Release Excipient Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pharma Sustained Release Excipient Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pharma Sustained Release Excipient Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kiloton)
Table 32. Europe Pharma Sustained Release Excipient Sales by Country (2025-2030) & (Kiloton)
Table 33. Europe Pharma Sustained Release Excipient Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pharma Sustained Release Excipient Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pharma Sustained Release Excipient Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pharma Sustained Release Excipient Sales by Region (2019-2024) & (Kiloton)
Table 37. Asia Pacific Pharma Sustained Release Excipient Sales by Region (2025-2030) & (Kiloton)
Table 38. Asia Pacific Pharma Sustained Release Excipient Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pharma Sustained Release Excipient Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pharma Sustained Release Excipient Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kiloton)
Table 42. Latin America Pharma Sustained Release Excipient Sales by Country (2025-2030) & (Kiloton)
Table 43. Latin America Pharma Sustained Release Excipient Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pharma Sustained Release Excipient Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pharma Sustained Release Excipient Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pharma Sustained Release Excipient Sales by Country (2019-2024) & (Kiloton)
Table 47. Middle East & Africa Pharma Sustained Release Excipient Sales by Country (2025-2030) & (Kiloton)
Table 48. Middle East & Africa Pharma Sustained Release Excipient Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pharma Sustained Release Excipient Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pharma Sustained Release Excipient Sales (Kiloton) by Type (2019-2024)
Table 51. Global Pharma Sustained Release Excipient Sales (Kiloton) by Type (2025-2030)
Table 52. Global Pharma Sustained Release Excipient Sales Market Share by Type (2019-2024)
Table 53. Global Pharma Sustained Release Excipient Sales Market Share by Type (2025-2030)
Table 54. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pharma Sustained Release Excipient Revenue Market Share by Type (2019-2024)
Table 57. Global Pharma Sustained Release Excipient Revenue Market Share by Type (2025-2030)
Table 58. Global Pharma Sustained Release Excipient Price (US$/Ton) by Type (2019-2024)
Table 59. Global Pharma Sustained Release Excipient Price (US$/Ton) by Type (2025-2030)
Table 60. Global Pharma Sustained Release Excipient Sales (Kiloton) by Application (2019-2024)
Table 61. Global Pharma Sustained Release Excipient Sales (Kiloton) by Application (2025-2030)
Table 62. Global Pharma Sustained Release Excipient Sales Market Share by Application (2019-2024)
Table 63. Global Pharma Sustained Release Excipient Sales Market Share by Application (2025-2030)
Table 64. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pharma Sustained Release Excipient Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pharma Sustained Release Excipient Revenue Market Share by Application (2019-2024)
Table 67. Global Pharma Sustained Release Excipient Revenue Market Share by Application (2025-2030)
Table 68. Global Pharma Sustained Release Excipient Price (US$/Ton) by Application (2019-2024)
Table 69. Global Pharma Sustained Release Excipient Price (US$/Ton) by Application (2025-2030)
Table 70. Teva Pharmaceutical Industries Corporation Information
Table 71. Teva Pharmaceutical Industries Description and Business Overview
Table 72. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product
Table 74. Teva Pharmaceutical Industries Recent Developments/Updates
Table 75. Mylan N.V. Corporation Information
Table 76. Mylan N.V. Description and Business Overview
Table 77. Mylan N.V. Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Mylan N.V. Pharma Sustained Release Excipient Product
Table 79. Mylan N.V. Recent Developments/Updates
Table 80. Valeant Pharmaceuticals International Corporation Information
Table 81. Valeant Pharmaceuticals International Description and Business Overview
Table 82. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product
Table 84. Valeant Pharmaceuticals International Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Pfizer Pharma Sustained Release Excipient Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Corporation Information
Table 91. Sun Pharmaceutical Industries Description and Business Overview
Table 92. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product
Table 94. Sun Pharmaceutical Industries Recent Developments/Updates
Table 95. Novartis AG Corporation Information
Table 96. Novartis AG Description and Business Overview
Table 97. Novartis AG Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Novartis AG Pharma Sustained Release Excipient Product
Table 99. Novartis AG Recent Developments/Updates
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. AstraZeneca Pharma Sustained Release Excipient Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. GlaxoSmithKline Pharma Sustained Release Excipient Product
Table 109. GlaxoSmithKline Recent Developments/Updates
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Business Overview
Table 112. Allergan Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Allergan Pharma Sustained Release Excipient Product
Table 114. Allergan Recent Developments/Updates
Table 115. Janssen Pharmaceuticals Corporation Information
Table 116. Janssen Pharmaceuticals Description and Business Overview
Table 117. Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Janssen Pharmaceuticals Pharma Sustained Release Excipient Product
Table 119. Janssen Pharmaceuticals Recent Developments/Updates
Table 120. Mayne Pharma Group Corporation Information
Table 121. Mayne Pharma Group Description and Business Overview
Table 122. Mayne Pharma Group Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Mayne Pharma Group Pharma Sustained Release Excipient Product
Table 124. Mayne Pharma Group Recent Developments/Updates
Table 125. BASF Corporation Information
Table 126. BASF Description and Business Overview
Table 127. BASF Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. BASF Pharma Sustained Release Excipient Product
Table 129. BASF Recent Developments/Updates
Table 130. International Flavors & Fragrances Corporation Information
Table 131. International Flavors & Fragrances Description and Business Overview
Table 132. International Flavors & Fragrances Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. International Flavors & Fragrances Pharma Sustained Release Excipient Product
Table 134. International Flavors & Fragrances Recent Developments/Updates
Table 135. Ashland Global Corporation Information
Table 136. Ashland Global Description and Business Overview
Table 137. Ashland Global Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 138. Ashland Global Pharma Sustained Release Excipient Product
Table 139. Ashland Global Recent Developments/Updates
Table 140. Evonik Industries Corporation Information
Table 141. Evonik Industries Description and Business Overview
Table 142. Evonik Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 143. Evonik Industries Pharma Sustained Release Excipient Product
Table 144. Evonik Industries Recent Developments/Updates
Table 145. Croda International Corporation Information
Table 146. Croda International Description and Business Overview
Table 147. Croda International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 148. Croda International Pharma Sustained Release Excipient Product
Table 149. Croda International Recent Developments/Updates
Table 150. Gattefosse Corporation Information
Table 151. Gattefosse Description and Business Overview
Table 152. Gattefosse Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 153. Gattefosse Pharma Sustained Release Excipient Product
Table 154. Gattefosse Recent Developments/Updates
Table 155. Merck KGaA Corporation Information
Table 156. Merck KGaA Description and Business Overview
Table 157. Merck KGaA Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 158. Merck KGaA Pharma Sustained Release Excipient Product
Table 159. Merck KGaA Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Pharma Sustained Release Excipient Distributors List
Table 163. Pharma Sustained Release Excipient Customers List
Table 164. Pharma Sustained Release Excipient Market Trends
Table 165. Pharma Sustained Release Excipient Market Drivers
Table 166. Pharma Sustained Release Excipient Market Challenges
Table 167. Pharma Sustained Release Excipient Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pharma Sustained Release Excipient
Figure 2. Global Pharma Sustained Release Excipient Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pharma Sustained Release Excipient Market Share by Type in 2023 & 2030
Figure 4. Gelatin Product Picture
Figure 5. Polymers Product Picture
Figure 6. Minerals Product Picture
Figure 7. Sugars Product Picture
Figure 8. Chitosan Product Picture
Figure 9. Global Pharma Sustained Release Excipient Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Pharma Sustained Release Excipient Market Share by Application in 2023 & 2030
Figure 11. Pharmaceutical
Figure 12. Health Care
Figure 13. Others
Figure 14. Global Pharma Sustained Release Excipient Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pharma Sustained Release Excipient Market Size (2019-2030) & (US$ Million)
Figure 16. Global Pharma Sustained Release Excipient Sales (2019-2030) & (Kiloton)
Figure 17. Global Pharma Sustained Release Excipient Average Price (US$/Ton) & (2019-2030)
Figure 18. Pharma Sustained Release Excipient Report Years Considered
Figure 19. Pharma Sustained Release Excipient Sales Share by Manufacturers in 2023
Figure 20. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Pharma Sustained Release Excipient Players: Market Share by Revenue in 2023
Figure 22. Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Pharma Sustained Release Excipient Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Pharma Sustained Release Excipient Sales Market Share by Country (2019-2030)
Figure 25. North America Pharma Sustained Release Excipient Revenue Market Share by Country (2019-2030)
Figure 26. United States Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Pharma Sustained Release Excipient Sales Market Share by Country (2019-2030)
Figure 29. Europe Pharma Sustained Release Excipient Revenue Market Share by Country (2019-2030)
Figure 30. Germany Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Pharma Sustained Release Excipient Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Pharma Sustained Release Excipient Revenue Market Share by Region (2019-2030)
Figure 37. China Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Pharma Sustained Release Excipient Sales Market Share by Country (2019-2030)
Figure 45. Latin America Pharma Sustained Release Excipient Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pharma Sustained Release Excipient Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Pharma Sustained Release Excipient Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Pharma Sustained Release Excipient Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Pharma Sustained Release Excipient by Type (2019-2030)
Figure 55. Global Revenue Market Share of Pharma Sustained Release Excipient by Type (2019-2030)
Figure 56. Global Pharma Sustained Release Excipient Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Sales Market Share of Pharma Sustained Release Excipient by Application (2019-2030)
Figure 58. Global Revenue Market Share of Pharma Sustained Release Excipient by Application (2019-2030)
Figure 59. Global Pharma Sustained Release Excipient Price (US$/Ton) by Application (2019-2030)
Figure 60. Pharma Sustained Release Excipient Value Chain
Figure 61. Pharma Sustained Release Excipient Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
